Baoxin Li

2.9k total citations · 1 hit paper
57 papers, 2.2k citations indexed

About

Baoxin Li is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Baoxin Li has authored 57 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 21 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Baoxin Li's work include Cardiac electrophysiology and arrhythmias (19 papers), Ion channel regulation and function (10 papers) and Berberine and alkaloids research (9 papers). Baoxin Li is often cited by papers focused on Cardiac electrophysiology and arrhythmias (19 papers), Ion channel regulation and function (10 papers) and Berberine and alkaloids research (9 papers). Baoxin Li collaborates with scholars based in China, United States and Canada. Baoxin Li's co-authors include Baofeng Yang, Chaoqian Xu, Yanjie Lu, Zhiguo Wang, Yunlong Bai, Huixian Lin, Jiening Xiao, Huizhen Wang, Guohao Chen and Ying Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and PLoS ONE.

In The Last Decade

Baoxin Li

56 papers receiving 2.2k citations

Hit Papers

The muscle-specific microRNA miR-1 regulates cardiac arrh... 2007 2026 2013 2019 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baoxin Li China 22 1.3k 729 564 171 162 57 2.2k
Jia‐Guo Zhou China 29 1.5k 1.2× 443 0.6× 335 0.6× 122 0.7× 142 0.9× 63 2.3k
Lin Shu-guang China 23 804 0.6× 414 0.6× 292 0.5× 151 0.9× 138 0.9× 50 1.7k
Shaoyu Zhou China 30 1.7k 1.3× 707 1.0× 381 0.7× 206 1.2× 182 1.1× 57 3.2k
Danny Ling Wang Taiwan 28 1.1k 0.9× 327 0.4× 478 0.8× 167 1.0× 68 0.4× 36 2.5k
Wenfeng Chu China 24 1.0k 0.8× 507 0.7× 358 0.6× 102 0.6× 47 0.3× 45 1.6k
Wu Luo China 26 1.3k 1.0× 244 0.3× 414 0.7× 138 0.8× 183 1.1× 92 2.5k
Tianlun Yang China 28 1.4k 1.1× 554 0.8× 502 0.9× 81 0.5× 42 0.3× 128 2.6k
Yun Ye China 27 779 0.6× 384 0.5× 286 0.5× 170 1.0× 53 0.3× 79 1.8k
Xiaoqiang Tang China 27 1.5k 1.2× 300 0.4× 402 0.7× 157 0.9× 88 0.5× 53 3.1k

Countries citing papers authored by Baoxin Li

Since Specialization
Citations

This map shows the geographic impact of Baoxin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoxin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoxin Li more than expected).

Fields of papers citing papers by Baoxin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baoxin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoxin Li. The network helps show where Baoxin Li may publish in the future.

Co-authorship network of co-authors of Baoxin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Baoxin Li. A scholar is included among the top collaborators of Baoxin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baoxin Li. Baoxin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuexin, Xiaoxu Li, Wenting Yu, et al.. (2025). Donepezil-induced degradation of hERG potassium channel via lysosomal pathway is exacerbated by hypoxia. European Journal of Pharmacology. 996. 177549–177549.
2.
Li, Yuexin, Xiaoxu Li, Yang Li, et al.. (2025). LncRNA MALAT1/Calpain-1 Axis in ATO Induced hERG Channel Deficiency. Drug Design Development and Therapy. Volume 19. 1475–1487. 1 indexed citations
3.
Wang, Fang, et al.. (2024). Chelerythrine triggers the prolongation of QT interval and induces cardiotoxicity by promoting the degradation of hERG channels. Journal of Biological Chemistry. 301(1). 108023–108023. 1 indexed citations
5.
Xue, Hui, Yuexin Li, Wenting Yu, et al.. (2022). Deacetylation mechanism and potential reversal strategy of long QT syndrome on hERG K+ channel under hypoxia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(11). 166487–166487. 3 indexed citations
6.
Wang, Fang, Xianghua Li, Yuexin Li, et al.. (2021). Rutaecarpine targets hERG channels and participates in regulating electrophysiological properties leading to ventricular arrhythmia. Journal of Cellular and Molecular Medicine. 25(11). 4938–4949. 13 indexed citations
7.
Chen, Jing, et al.. (2016). Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma. Oncology Letters. 12(6). 4961–4968. 5 indexed citations
8.
Gao, Chunyan, Rui Xie, Chengyuan Yu, et al.. (2015). Thrombotic Role of Blood and Endothelial Cells in Uremia through Phosphatidylserine Exposure and Microparticle Release. PLoS ONE. 10(11). e0142835–e0142835. 40 indexed citations
9.
Yan, Meng, Lirong Liu, Xiao Zhang, et al.. (2015). High Glucose Represses hERG K+ Channel Expression through Trafficking Inhibition. Cellular Physiology and Biochemistry. 37(1). 284–296. 26 indexed citations
10.
Zhang, Kaiping, Ting Huang, Yan Gong, et al.. (2014). Berberine Induces hERG Channel Deficiency through Trafficking Inhibition. Cellular Physiology and Biochemistry. 34(3). 691–702. 20 indexed citations
11.
Wang, Yang, et al.. (2012). Unilateral left pulmonary vein atresia: radiologic findings in an adult case.. Europe PMC (PubMed Central). 1 indexed citations
12.
Yin, Ji‐Bin, et al.. (2011). The Cyclooxygenase-2 Inhibitor Celecoxib Attenuates Hepatocellular Carcinoma Growth and c-Met Expression in an Orthotopic Mouse Model. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(3). 131–139. 12 indexed citations
13.
Han, Na, et al.. (2011). Limited hippocampal neurogenesis in SAMP8 mouse model of Alzheimer's disease. Brain Research. 1389. 183–193. 33 indexed citations
14.
Zhang, Yong, Zhang Li, Wenfeng Chu, et al.. (2010). Tanshinone IIA Inhibits miR-1 Expression through p38 MAPK Signal Pathway in Post-infarction Rat Cardiomyocytes. Cellular Physiology and Biochemistry. 26(6). 991–998. 74 indexed citations
15.
Hu, Meiqin, Zengxiang Dong, Jing Sun, et al.. (2010). The Novel Mechanism of Oxymatrine Affecting hERG Currents at Different Temperatures. Cellular Physiology and Biochemistry. 26(4-5). 513–522. 7 indexed citations
16.
Shan, Hongli, Xuelian Li, Zhenwei Pan, et al.. (2009). Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA‐1. British Journal of Pharmacology. 158(5). 1227–1235. 91 indexed citations
17.
Lu, Yanjie, Yong Zhang, Hongli Shan, et al.. (2009). MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovascular Research. 84(3). 434–441. 131 indexed citations
18.
Qi, Zhiping, Shanshan Shi, Yunlong Bai, et al.. (2008). [Effect of sophocarpine on HERG K+ channels].. PubMed. 43(1). 44–9. 4 indexed citations
19.
Yang, Baofeng, Huixian Lin, Jiening Xiao, et al.. (2007). The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature Medicine. 13(4). 486–491. 897 indexed citations breakdown →
20.
Zhang, Yan, Yanyan Liu, Tao Wang, et al.. (2006). Resveratrol, a natural ingredient of grape skin: Antiarrhythmic efficacy and ionic mechanisms. Biochemical and Biophysical Research Communications. 340(4). 1192–1199. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026